Diagnostic Laboratories and Hospitals to Remain Primary End Users in Antimicrobial Susceptibility Test Market
Recent times have witnessed a marked shift towards personalised medicines, which is increasing the demand for antimicrobial susceptibility testing products. Rising government initiatives regarding the development of quality hospital infrastructure, on a global level, and surging susceptibility to infectious diseases, are projected to complement the demand for antimicrobial susceptibility tests in diagnostic laboratories and hospitals during the forecast period (2020-2025).
Besides these institutes, antimicrobial susceptibility test kits are gaining traction in the pharmaceutical and biotechnology sectors for the research & development of new drugs to fight bacteria. In the future, online sales channels will remain a crucial propeller to the growth of the antimicrobial susceptibility test market, as market players intend to penetrate local markets.
For detailed insights on market taxonomy, request a sample copy of the report here.
High R&D Investments Restrict Market Opportunities to Leading Players
Low return on investment in the antimicrobial susceptibility market is a crucial challenge for manufacturers. Unlike therapeutics used to treat chronic illnesses, antimicrobial drugs are prescribed for a limited time. However, capital expended during the development and marketing phases falls short of desired returns with the limited consumption of drugs. Moreover, high investment capacities in research & development activities will offer leading players in the antimicrobial susceptibility test market an edge over regional and local players.
Given this influence, small- and mid-level players are finding it difficult to make a breakthrough in the antimicrobial susceptibility test market. Besides this, scientific and regulatory challenges encountered by manufacturers in the antimicrobial susceptibility test market further extend the time to market and increase the cost of development, which could hamper the on-time marketability of products.
Time-efficiency to Remain Central to Foster Innovation
Antibacterial drugs have been playing a pivotal role in the prevention of infectious diseases; however, several cases of drug abuse, during the animal breeding process, have led to the development drug resistance. The excessive use of drugs to control microbial infections is leading to drug wastage, thereby causing economic loss to livestock farmers. Delay caused in diagnosing harmful bacteria further makes it difficult to control the spread of infection altogether. This is putting enormous pressure on players in the antimicrobial susceptibility test market to develop test kits that offer accurate results in a short duration of time.
Although fast techniques are readily available for identifying bacteria, determining drug susceptibility still significantly depends on traditional methods, with turnaround times in the range of 24 to 48 hours. This makes it imperative for market players to amplify their focus on improving the turnaround time to have a better exposure in the antimicrobial susceptibility test market.
Online Sales Channel - Winning Strategy
The online purchase of antimicrobial susceptibility test kits is projected to evolve as a significant trend during the forecast period of 2020-2025. This is encouraging numerous vendors to improve their online brand recognition value through effective marketing efforts and promotional strategies. The emergence of these channels will also translate into reduced costs, which are otherwise incurred by brick-and-mortar distribution centres for maintenance purposes. In addition, this is expected to prove beneficial for players to increase their exposure in the antimicrobial susceptibility test market. Through effective online marketing techniques, market players can also create awareness regarding the key features of their products, which will further boost the sales prospects of antimicrobial susceptibility test products.
For detailed regional analysis, request a sample copy of the report here.
Impact of Top Market Trends on North America
In 2019, North America accounted for ~34% of the total share in the global antimicrobial susceptibility test market, which is projected to further increase by 2025. Top trends influencing the global antimicrobial susceptibility test market include increasing microbial resistance, rise in public-private partnerships, regulatory barriers, technological advancements, and impact of traditional methods. Among these dynamics, the impressive technical prowess of players operating from North America has a high influence on technological advancements of antimicrobial susceptible test products. However, the presence of stringent regulations in the healthcare sector is projected to demand a lot of manufacturers’ time and efforts in receiving an 'Okay Tested' approval for their products.
Besides this, public health, being the key agenda of the government in the region, is found to have a positive impact on public-private partnerships in North America. This is also projected to serve as an instrument to accelerate the pace of product development for market players.
Request research methodology of this report.
Antimicrobial Susceptibility Test Market – Scope of the Study
The study on the antimicrobial susceptibility test market is an exclusive report published by Fact.MR, which highlights the key parameters that are influencing the growth of the landscape. This study offers insights on the growth of the antimicrobial susceptibility test market, by analyzing the historical data for the period of 2015-2019, and 2020-2025 as the forecast period. Estimation of the revenue of the antimicrobial susceptibility test market has been carried out in terms of value (US$ Mn). This research highlights the key trends that hold the potential to influence the growth of the antimicrobial susceptibility test market, along with crucial macroeconomic and microeconomic growth indicators. This insightful report offers key dynamics, and their impact on the value chain, which are projected to influence the future growth of the antimicrobial susceptibility test market.
The study also includes a detailed section dedicated to impeders that could challenge the growth of players in the antimicrobial susceptibility test market. The report unfolds lucrative opportunities for market players, which they can leverage to consolidate their position in the global market. With a view of aiding stakeholders in the antimicrobial susceptibility test market, the study comprises a detailed section on the competition analysis. The study offers a dashboard view of the report, with a comprehensive comparison of players operating in the antimicrobial susceptibility test market, based on total revenue, market presence, and key developments. Besides this, the recent developments and key strategies of players in the antimicrobial susceptibility test market have also been included in this comprehensive study.
Antimicrobial Susceptibility Test Market – Assessment of Key Segments
Authors of the report have segmented the antimicrobial susceptibility test market into key categories in order to study the market at a microscopic level. The key segments considered while bifurcating the antimicrobial susceptibility test market include:
|
Product |
Method |
Test Type |
Application |
End User |
Region |
|
Kits, Reagents, & Consumables |
Broth Dilution Method |
Antibacterial |
Clinical Diagnosis |
Diagnostic Laboratories and Hospitals |
North America |
|
Automated Test Systems |
Rapid Automated Method |
Antiparasitic |
Drug Discovery and Development |
Research and Academic Institutes |
Latin America |
|
Culture Media |
Disk Diffusion Method |
Antifungal |
Others |
Pharmaceutical and Biotechnology Companies |
Europe |
|
|
Gradient Diffusion Method |
Others |
|
Contract Research Organizations |
Asia Pacific |
|
|
Molecular Testing Method |
|
|
|
Middle East & Africa |
Besides laying focus on the aforementioned key segments, the report also studies the antimicrobial susceptibility test market at a country level, to recalibrate the underlying opportunities available for players in the antimicrobial susceptibility test market for the forecast period. Among all the estimated data, the report also includes Y-o-Y growth projections, which can help market players in comprehending the precise trajectory at which the antimicrobial susceptibility test market has been growing.
Key companies profiled in the report on antimicrobial susceptibility test market include bioMérieux SA, Beckman Coulter, Inc., Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Alifax Holding S.p.A., Creative Diagnostics, Becton, Dickinson and Company, HiMedia Laboratories, Cepheid, Biotron Healthcare, and Conda.
Antimicrobial Susceptibility Test Market – Research Methodology
The antimicrobial susceptibility test market has been evaluated by taking a top-down and bottom-up approach. Demand, geographical presence, distribution strategies by manufacturers, and initiatives taken by governments and NGOs are various factors considered while estimating the revenue of the antimicrobial susceptibility test market for each device, and thus, reaching global numbers. The study on the antimicrobial susceptibility test market is further validated through extensive primary research on the data extracted from exhaustive secondary research.
In order to conduct secondary research, annual company reports, company websites, data from the World Health Organization (WHO), SEC filings, press releases, investor presentations, and other similar resources were studied. To validate the information compiled through secondary research, interviews with key opinion leaders and subject matter experts were scheduled. In addition to this, authors of the report also had email and telephonic interactions with the senior management of leading and prominent companies to confirm the size, growth trends, and future outlook of the antimicrobial susceptibility test market.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary : Global Antimicrobial Susceptibility Test Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Antimicrobial Susceptibility Test Market Analysis and Forecasts, 2015–2025
4.4.1. Market Revenue Projections (US$ Mn)
4.5. Antimicrobial Susceptibility Test Market - Global Supply Demand Scenario
4.6. Porter’s Five Force Analysis
4.8. Value Chain Analysis & Supply-Demand Scenario
4.9. Antibacterial Drugs Pipeline Analysis
4.10. Regulatory Scenario
4.11. Market Outlook
5. Global Antimicrobial Susceptibility Test Market Analysis and Forecasts, By Product
5.1. Introduction & Definition
5.2. Key Findings
5.3. Market Value Forecast By Product , 2015–2025
5.3.1. Test & Kits
5.3.2. Culture Media
5.3.3. Automated Test System
5.3.4. Consumables
5.4. Market Attractiveness By Product
6. Global Antimicrobial Susceptibility Test Market Analysis and Forecasts, By Method
6.1. Introduction & Definition
6.2. Key Findings
6.3. Market Value Forecast By Method , 2015–2025
6.3.1. Broth Dilution Method
6.3.2. Rapid Automated Method
6.3.3. Disk Diffusion Method
6.3.4. Gradient Diffusion Method
6.3.5. Molecular Testing Method
6.4. Market Attractiveness By Method
7. Global Antimicrobial Susceptibility Test Market Analysis and Forecasts, By Test Type
7.1. Introduction & Definition
7.2. Key Findings
7.3. Market Value Forecast By Test Type , 2015–2025
7.3.1. Antibacterial
7.3.2. Antifungal
7.3.3. Antiparasitics
7.3.4. Others
7.4. Market Attractiveness By Test Type
8. Global Antimicrobial Susceptibility Test Market Analysis and Forecasts, By Application
8.1. Introduction & Definition
8.2. Key Findings
8.3. Market Value Forecast By Application , 2015–2025
8.3.1. Clinical Diagnosis
8.3.2. Drug Discovery and Development
8.3.3. Others
8.4. Market Attractiveness By Application
9. Global Antimicrobial Susceptibility Test Market Analysis and Forecasts, By End User
9.1. Introduction & Definition
9.2. Key Findings
9.3. Market Value Forecast By End User , 2015–2025
9.3.1. Diagnostic Laboratories and Hospitals
9.3.2. Pharmaceutical and Biotechnology Companies
9.3.3. Research and Academic Institutes
9.3.4. Contract Research Organizations
9.4. Market Attractiveness By End User
10. Global Antimicrobial Susceptibility Test Market Analysis and Forecasts, By Region
10.1. Key Findings
10.2. Market Value Forecast By Region
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Market Attractiveness By Country/Region
11. North America Antimicrobial Susceptibility Test Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast By Product , 2015–2025
11.2.1. Test & Kits
11.2.2. Culture Media
11.2.3. Automated Test System
11.2.4. Consumables
11.3. Market Value Forecast By Method , 2015–2025
11.3.1. Broth Dilution Method
11.3.2. Rapid Automated Method
11.3.3. Disk Diffusion Method
11.3.4. Gradient Diffusion Method
11.3.5. Molecular Testing Method
11.4. Market Value Forecast By Test Type , 2015–2025
11.4.1. Antibacterial
11.4.2. Antifungal
11.4.3. Antiparasitics
11.4.4. Others
11.5. Market Value Forecast By Application , 2015–2025
11.5.1. Clinical Diagnosis
11.5.2. Drug Discovery and Development
11.5.3. Others
11.6. Market Value Forecast By End User , 2015–2025
11.6.1. Diagnostic Laboratories and Hospitals
11.6.2. Pharmaceutical and Biotechnology Companies
11.6.3. Research and Academic Institutes
11.6.4. Contract Research Organizations
11.7. Market Value Forecast By Country , 2015–2025
11.7.1. U.S.
11.7.2. Canada
11.8. Market Attractiveness Analysis
11.8.1. By Product
11.8.2. By Method
11.8.3. By Test Type
11.8.4. By Application
11.8.5. By End User
11.8.6. By Country
12. Europe Antimicrobial Susceptibility Test Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast By Product , 2015–2025
12.2.1. Test & Kits
12.2.2. Culture Media
12.2.3. Automated Test System
12.2.4. Consumables
12.3. Market Value Forecast By Method , 2015–2025
12.3.1. Broth Dilution Method
12.3.2. Rapid Automated Method
12.3.3. Disk Diffusion Method
12.3.4. Gradient Diffusion Method
12.3.5. Molecular Testing Method
12.4. Market Value Forecast By Test Type , 2015–2025
12.4.1. Antibacterial
12.4.2. Antifungal
12.4.3. Antiparasitics
12.4.4. Others
12.5. Market Value Forecast By Application , 2015–2025
12.5.1. Clinical Diagnosis
12.5.2. Drug Discovery and Development
12.5.3. Others
12.6. Market Value Forecast By End User , 2015–2025
12.6.1. Diagnostic Laboratories and Hospitals
12.6.2. Pharmaceutical and Biotechnology Companies
12.6.3. Research and Academic Institutes
12.6.4. Contract Research Organizations
12.7. Market Value Forecast By Country , 2015–2025
12.7.1. Germany
12.7.2. U.K.
12.7.3. France
12.7.4. Spain
12.7.5. Italy
12.7.6. Rest of Europe
12.8. Market Attractiveness Analysis
12.8.1. By Product
12.8.2. By Method
12.8.3. By Test Type
12.8.4. By Application
12.8.5. By End User
12.8.6. By Country
13. Asia Pacific Antimicrobial Susceptibility Test Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast By Product , 2015–2025
13.2.1. Test & Kits
13.2.2. Culture Media
13.2.3. Automated Test System
13.2.4. Consumables
13.3. Market Value Forecast By Method , 2015–2025
13.3.1. Broth Dilution Method
13.3.2. Rapid Automated Method
13.3.3. Disk Diffusion Method
13.3.4. Gradient Diffusion Method
13.3.5. Molecular Testing Method
13.4. Market Value Forecast By Test Type , 2015–2025
13.4.1. Antibacterial
13.4.2. Antifungal
13.4.3. Antiparasitics
13.4.4. Others
13.5. Market Value Forecast By Application , 2015–2025
13.5.1. Clinical Diagnosis
13.5.2. Drug Discovery and Development
13.5.3. Others
13.6. Market Value Forecast By End User , 2015–2025
13.6.1. Diagnostic Laboratories and Hospitals
13.6.2. Pharmaceutical and Biotechnology Companies
13.6.3. Research and Academic Institutes
13.6.4. Contract Research Organizations
13.7. Market Value Forecast By Country , 2015–2025
13.7.1. Japan
13.7.2. China
13.7.3. India
13.7.4. Rest of Asia Pacific
13.8. Market Attractiveness Analysis
13.8.1. By Product
13.8.2. By Method
13.8.3. By Test Type
13.8.4. By Application
13.8.5. By End User
13.8.6. By Country
14. Latin America Antimicrobial Susceptibility Test Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast By Product , 2015–2025
14.2.1. Test & Kits
14.2.2. Culture Media
14.2.3. Automated Test System
14.2.4. Consumables
14.3. Market Value Forecast By Method , 2015–2025
14.3.1. Broth Dilution Method
14.3.2. Rapid Automated Method
14.3.3. Disk Diffusion Method
14.3.4. Gradient Diffusion Method
14.3.5. Molecular Testing Method
14.4. Market Value Forecast By Test Type , 2015–2025
14.4.1. Antibacterial
14.4.2. Antifungal
14.4.3. Antiparasitics
14.4.4. Others
14.5. Market Value Forecast By Application , 2015–2025
14.5.1. Clinical Diagnosis
14.5.2. Drug Discovery and Development
14.5.3. Others
14.6. Market Value Forecast By End User , 2015–2025
14.6.1. Diagnostic Laboratories and Hospitals
14.6.2. Pharmaceutical and Biotechnology Companies
14.6.3. Research and Academic Institutes
14.6.4. Contract Research Organizations
14.7. Market Value Forecast By Country , 2015–2025
14.7.1. Brazil
14.7.2. Mexico
14.7.3. Rest of Latin America
14.8. Market Attractiveness Analysis
14.8.1. By Product
14.8.2. By Method
14.8.3. By Test Type
14.8.4. By Application
14.8.5. By End User
14.8.6. By Country
15. Middle East & Africa Antimicrobial Susceptibility Test Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast By Product , 2015–2025
15.2.1. Test & Kits
15.2.2. Culture Media
15.2.3. Automated Test System
15.2.4. Consumables
15.3. Market Value Forecast By Method , 2015–2025
15.3.1. Broth Dilution Method
15.3.2. Rapid Automated Method
15.3.3. Disk Diffusion Method
15.3.4. Gradient Diffusion Method
15.3.5. Molecular Testing Method
15.4. Market Value Forecast By Test Type , 2015–2025
15.4.1. Antibacterial
15.4.2. Antifungal
15.4.3. Antiparasitics
15.4.4. Others
15.5 .Market Value Forecast By Application , 2015–2025
15.5.1. Clinical Diagnosis
15.5.2. Drug Discovery and Development
15.5.3. Others
15.6. Market Value Forecast By End User , 2015–2025
15.6.1. Diagnostic Laboratories and Hospitals
15.6.2. Pharmaceutical and Biotechnology Companies
15.6.3. Research and Academic Institutes
15.6.4. Contract Research Organizations
15.7. Market Value Forecast By Country , 2015–2025
15.7.1. South Africa
15.7.2. GCC Countries
15.7.3. Israel
15.7.4. Rest of Middle East and Africa
15.8. Market Attractiveness Analysis
15.8.1. By Product
15.8.2. By Method
15.8.3. By Test Type
15.8.4. By Application
15.8.5. By End User
15.8.6. By Country
16. Competition Landscape
16.1. Market Player – Competition Matrix (By Tier and Size of companies)
16.2. Market Share Analysis By Company (2016)
16.3. Company Profiles (Details – Overview, Financials, Recent Developments, Strategy)
16.3.1. Bio-Rad Laboratories, Inc.
16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.1.2. Financial Overview
16.3.1.3. Product Portfolio
16.3.1.4. SWOT Analysis
16.3.1.5. Strategic Overview
16.3.2. Beckman Coulter, Inc. (Subsidiary of Danaher Corporation)
16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.1.2. Financial Overview
16.3.1.3. Product Portfolio
16.3.1.4. SWOT Analysis
16.3.1.5. Strategic Overview
16.3.3. Thermo Fisher Scientific, Inc.
16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.1.2. Financial Overview
16.3.1.3. Product Portfolio
16.3.1.4. SWOT Analysis
16.3.1.5. Strategic Overview
16.3.4. Becton, Dickinson and Company
16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.1.2. Financial Overview
16.3.1.3. Product Portfolio
16.3.1.4. SWOT Analysis
16.3.1.5. Strategic Overview
16.3.5. Conda
16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.1.2. Financial Overview
16.3.1.3. Product Portfolio
16.3.1.4. SWOT Analysis
16.3.1.5. Strategic Overview
16.3.6. Creative Diagnostics
16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.1.2. Financial Overview
16.3.1.3. Product Portfolio
16.3.1.4. SWOT Analysis
16.3.1.5. Strategic Overview
16.3.7. HiMedia Laboratories
16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.1.2. Financial Overview
16.3.1.3. Product Portfolio
16.3.1.4. SWOT Analysis
16.3.1.5. Strategic Overview
16.3.8. Alifax Holding S.p.A.
16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.1.2. Financial Overview
16.3.1.3. Product Portfolio
16.3.1.4. SWOT Analysis
16.3.1.5. Strategic Overview
16.3.9. Danaher Corporation (Cepheid)
16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.1.2. Financial Overview
16.3.1.3. Product Portfolio
16.3.1.4. SWOT Analysis
16.3.1.5. Strategic Overview
16.3.10. Biotron Healthcare
16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.1.2. Financial Overview
16.3.1.3. Product Portfolio
16.3.1.4. SWOT Analysis
16.3.1.5. Strategic Overview
Fact.MR offers custom research services that help clients to get specific research solutions
We are committed towards customer satisfaction and quality service.
Antimicrobial Susceptibility Test Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2020 to 2025